Table 1.
Status of Drugs in Phase III Development for Selected Psychiatric Disorders
| Disorder a | Total number of open or active Phase III drug trials |
Classification of those drugs in open or active Phase III drug trials |
||
|---|---|---|---|---|
| Number of drugs under study b |
Number of drugs not yet approved by the FDA for any purpose c |
Number of new drugs representing substantial departure from existing treatment |
||
| Alcohol use disorders | 11 | 9 | 0 | 0 |
| Anxiety | 8 | 7 | 0 | 0 |
| ADHD | 3 | 2 | 0 | 0 |
| Bipolar Disorder | 17 | 13 | 0 | 0 |
| Depression | 23 | 18 | 4 | 1 |
| Insomnia | 5 | 9 | 1 | 0 |
| Schizophrenia | 32 | 10 | 5 | 2 |
a
Some trials are found under multiple disorders (e.g., treatment for comorbid alcohol and PTSD).)
b
Some drugs are studied in combination with other drugs that are also counted.
c
Also excluded from this count are any drugs currently marketed as supplements.